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We assessed the impact of the heptavalent pneumococ-
cal conjugate vaccine (PCV7) on the nasopharyngeal
carriage of Streptococcus pneumoniae in healthy children
aged 2 to 24 months, four years after its implementation
in New Caledonia. The data were compared with those
obtained, before the introduction of the vaccine, in the
same target population
From February to October 2008, 592 children were
enrolled prospectively, regardless of their vaccinal status.
Between 2002 and 2008, the prevalence of the overall
pneumococcal carriage and of vaccine type carriage
decreased significantly, respectively 52.3% to 42.1% (p<
10
-3) and 46.9% to 22.2% (p < 10
-3). This reduction was
offset by an increase (20.8% to 29.0%, p = 0.013)o ft h e
carriage of non-vaccine type pneumococci with reduced
susceptibility to penicillin (PRSP), notably the serotypes
15B (p=0.027)a n d1 9 A( p=0.001). This increase in
PRSP carriage was marked in the Northern Province
(p = 0.005) and among Melanesian children (p = 0.009).
Surprisingly this increase was mainly attributed to the
vaccine type 19F (p<1 0
-3).
In conclusion, as expected, the PCV7 vaccine led to a
decrease of the pneumococcal carriage and the replace-
ment of vaccine strains by non vaccine strains, how-
ever increasingly resistant to penicillin. In the
Northern Province, the increasing carriage of penicillin
resistant 19F strains escaping the vaccine is of concern
and justifies a further comprehensive analysis using
MLST genotyping.
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